| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
2 companies
Heuszel Frank D serves as a Chief Executive Officer at DSS and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 4 buys and 0 sells. Those positions are worth an estimated $715K at current prices.
Historically, Heuszel Frank D's trades have earned a below-average insider score of 12/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -82.6%.
The biggest single holding is DSS (~$673K) as Chief Executive Officer.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | IBO Impact Biomedical Inc. | Chief Executive Officer | Buy | 500 | $2.26 | $1,128.90 | +0.5% | -48.2% | -79.9% | |
| Nov 27, 2024 | IBO Impact Biomedical Inc. | Chief Executive Officer | Buy | 500 | $2.61 | $1,305.00 | +0.5% | -32.7% | -83.8% | |
| Nov 26, 2024 | IBO Impact Biomedical Inc. | Chief Executive Officer | Buy | 1,050 | $2.61 | $2,738.75 | +0.5% | -22.4% | -84.2% |